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The Effect of Incentive Spirometry on Postoperative
Pulmonary Function Following Laparotomy
A Randomized Clinical Trial
Anna F. Tyson, MD; Claire E. Kendig, BS; Charles Mabedi, MB, BS; Bruce A. Cairns, MD; Anthony G. Charles, MD, MPH
IMPORTANCE Changes in pulmonary dynamics following laparotomy are well documented.
Deep breathing exercises, with or without incentive spirometry, may help counteract
postoperative decreased vital capacity; however, the evidence for the role of incentive
spirometry in the prevention of postoperative atelectasis is inconclusive. Furthermore, data
are scarce regarding the prevention of postoperative atelectasis in sub-Saharan Africa.
OBJECTIVE To determine the effect of the use of incentive spirometry on pulmonary function
following exploratory laparotomy as measured by forced vital capacity (FVC).
DESIGN, SETTING, AND PARTICIPANTS This was a single-center, randomized clinical trial
performed at Kamuzu Central Hospital, Lilongwe, Malawi. Study participants were adult
patients who underwent exploratory laparotomy and were randomized into the intervention
or control groups (standard of care) from February 1 to November 30, 2013. All patients
received routine postoperative care, including instructions for deep breathing and early
ambulation. We used bivariate analysis to compare outcomes between the intervention and
control groups.
INTERVENTION Adult patients who underwent exploratory laparotomy participated in
postoperative deep breathing exercises. Patients in the intervention group received incentive
spirometers.
MAIN OUTCOMES AND MEASURES We assessed pulmonary function using a peak flow meter
to measure FVC in both groups of patients. Secondary outcomes, such as hospital length of
stay and mortality, were obtained from the medical records.
RESULTS A total of 150 patients were randomized (75 in each arm). The median age in the
intervention and control groups was 35 years (interquartile range, 28-53 years) and 33 years
(interquartile range, 23-46 years), respectively. Men predominated in both groups, and most
patients underwent emergency procedures (78.7% in the intervention group and 84.0% in
the control group). Mean initial FVC did not differ significantly between the intervention and
control groups (0.92 and 0.90 L, respectively; P = .82 [95% CI, 0.52-2.29]). Although
patients in the intervention group tended to have higher final FVC measurements, the change
between the first and last measured FVC was not statistically significant (0.29 and 0.25 L,
respectively; P = .68 [95% CI, 0.65-1.95]). Likewise, hospital length of stay did not differ
significantly between groups. Overall postoperative mortality was 6.0%, with a higher
mortality rate in the control group compared with the intervention group (10.7% and 1.3%,
respectively; P = .02 [95% CI, 0.01-0.92]).
CONCLUSIONS AND RELEVANCE Education and provision of incentive spirometry for
unmonitored patient use does not result in statistically significant improvement in pulmonary
dynamics following laparotomy. We would not recommend the addition of incentive
spirometry to the current standard of care in this resource-constrained environment.
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P ostoperative pulmonary complications (PPC) follow-ing laparotomy are common and present a significantburden to health care systems by increasing health care
costs, resource utilization, hospital length of stay, morbidity,
and mortality.1-5 The frequency of PPC after laparotomy re-
ported in the literature varies widely, ranging from 20% to 90%
for atelectasis and 9% to 40% for postoperative pneumonia.3-16
Risk factors include older age, smoking, malnutrition, preop-
erative or intraoperative blood loss, emergency surgery, and
upper abdominal or thoracic surgery.2-5,8,17-19
The functional mechanisms associated with the onset of
PPC are not completely understood but likely involve a com-
bination of decreased lung volume resulting in atelectasis and
impaired mucociliary clearance.1,4-6,17,18 Deep breathing and
coughing exercises may help mobilize secretions and reex-
pand areas of collapsed lung postoperatively. The resultant sus-
tained alveolar inflation and maintenance of normal func-
tional residual capacity is thought to prevent PPC.5
Incentive spirometry (IS) is a breathing technique in which
deep breathing exercises are performed through a device of-
fering visual feedback in terms of inspired flow and volume.
The addition of visual feedback is thought to improve breath-
ing technique and increase patient motivation.20 Use of IS has
gained substantial popularity in high-income countries since
it was first introduced by Bartlett et al20 in 1973 and is now con-
sidered the standard of care in the postoperative period.3,5,21
However, postoperative interventions to prevent PPC have
demonstrated mixed results. Although some reviews have
shown decreased incidence of PPC and length of stay in pa-
tients using IS,9 others have found little benefit from this
intervention.5,21,22
Data on PPC in low- and middle-income countries are
scarce; however, the burden of health care–associated infec-
tions in low- and middle-income countries is high.23,24 Lim-
ited data suggest that health care–associated infections25
and surgical site infections26-29 are more common in sub-
Saharan Africa than in high-income countries and that
patients in sub-Saharan Africa with health care–associated
infections have longer lengths of stay. However, to our
knowledge, no studies have reported the incidence of PPC in
sub-Saharan African settings, examined the effect of PPC on
mortality in this setting, or described interventions designed
to reduce PPC.
Given the contradictory nature of the data in high-
income settings and paucity of data in sub-Saharan Africa, we
conducted a prospective randomized trial of postoperative IS
in adult patients in sub-Saharan Africa who underwent lapa-
rotomy in a resource-poor setting.
Methods
Study Design
This study was a single-center, randomized clinical trial per-
formed at Kamuzu Central Hospital in Lilongwe, Malawi. Ka-
muzu Central Hospital is a 600-bed tertiary care facility serv-
ing a catchment population of approximately 5 million people
in central Malawi. Adult patients of both sexes and all ethnic
groups who underwent laparotomy by a general surgeon at Ka-
muzu Central Hospital were eligible for enrollment.
A total of 150 patients were enrolled, 75 in each arm, using
an intention-to-treat model (Figure 1). Eligible patients were
identified from the operating theater log; a blinded research
assistant approached patients for consent. Consenting pa-
tients were randomized into treatment or control groups using
permuted block randomization in blocks of 4, 6, and 8. The ran-
domization sequence was developed before the initiation of
the trial and concealed until after enrollment. Following ran-
domization, peak flow measurements and data analysis were
not blinded. The primary surgical team treating the patients
and diagnosing postoperative complications was blinded to
randomization. The institutional review boards at the Univer-
sity of North Carolina and the Malawi National Health Sci-
ences Review Committee approved this trial. Written in-
formed consent was obtained from all participants.
Participants
Participants met inclusion criteria for this study if they were
at least 18 years of age and underwent elective or emergency
laparotomy by a general surgeon. Patients were excluded if they
were younger than 18 years, if they were not general surgery
patients, if they were unable or unwilling to participate, if they
were admitted to the intensive care unit or high-dependency
unit postoperatively, if they underwent tracheostomy or were
left intubated postoperatively, or if they could not be located
or recruited within 3 days of the initial operation.
Intervention
After randomization, patients in the study arm received the
DISPIRO Disposable Spirometer System (Utah Medical Prod-
ucts Inc), in addition to deep breathing instructions. Patients
in the control arm were given the standard of care only.
Measures
All patients had peak flow measurements performed on en-
rollment and every 2 to 3 days postoperatively. All patients re-
ceived the standard postoperative pain control and instruc-
tions for deep breathing, coughing, and early ambulation.
Patients in the intervention group were instructed to fully in-
flate the incentive spirometer every hour. Neither the re-
search staff nor the hospital staff supervised or recorded the
use of spirometers during follow-up. Peak flow measure-
ments ended when the patient was discharged, if the patient
became ineligible, or after 6 measurements if the peak flow
measurements stabilized but discharge was delayed for non-
pulmonary complications. Patients who became ineligible were
included up to the point of withdrawal, after which time no
additional peak flow measurements were taken, but final out-
come and hospital length of stay were recorded from the medi-
cal record. Demographic and clinical information were ob-
tained from the medical record and the operative log.
The primary outcome of interest of this study is change in
pulmonary function, using forced vital capacity (FVC) mea-
surements, between the patients’ first and last measure-
ments. We hypothesized that patients with incentive spirom-
eters would have a faster return to normal FVC and baseline
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pulmonary function compared with patients without spirom-
eters. Secondary outcomes were hospital length of stay and
mortality. We were unable to measure incidence of pulmo-
nary complications due to diagnostic limitations and poor
documentation. Cause of death was abstracted, when avail-
able, from the medical record. The primary surgical team was
solely responsible for all postoperative diagnostic and thera-
peutic decision making and documentation in the medical rec-
ord. No additional diagnostic tests were performed for this trial.
Statistical Analysis
The study was powered to detect a 20% difference in final FVC
measurements between the intervention and control groups.
We used means, medians, and percentages to describe the base-
line characteristics of the study participants and bivariate analy-
sis to assess randomization between the intervention and con-
trol groups. We used the Pearson χ2 test to compare categorical
secondary outcomes, t test for normally distributed continu-
ous variables, and K-sample equality-of-means test for badly
skewed continuous variables. We also performed subgroup
analysis for trauma patients and patients with known or sus-
pected cancer.
Results
A total of 371 adult exploratory laparotomy cases were per-
formed at Kamuzu Central Hospital between February 1 and
November 30, 2013. Of these, 150 patients were enrolled in the
trial, and 75 patients were randomized to each arm (Figure 1).
The median age in the intervention and control groups was 35
and 33 years, respectively (range, 18-78 years). Men predomi-
nated in both groups, and most patients underwent emer-
gency procedures (78.7% in the intervention group and 84.0%
in the control group). Diagnoses and procedures performed
were similar between the control and intervention groups
(Table 1). Most patients were enrolled within 2 days of explor-
atory laparotomy and underwent between 2 and 3 FVC mea-
surements.
Mean initial FVC did not differ significantly between the
intervention and control groups (0.92 and 0.90 L, respec-
tively; P = .82 [95% CI, 0.52-2.29]). Although patients in the in-
tervention group tended to have higher final FVC measure-
ments, the change in FVC between initial and final
measurements was not statistically different between the IS
arm compared with that in the control arm (0.29 and 0.25 L,
respectively; P = .68 [95% CI, 0.65-1.95]) (Table 1 and Figure 2).
Hospital length of stay did not differ significantly be-
tween groups. Pulmonary complications were rarely docu-
mented in the medical record. Two patients had documented
clinical impressions of potential pulmonary complications con-
tributing to death, although neither underwent laboratory or
radiologic testing. Nine patients died, resulting in an overall
postoperative mortality of 6.0%. Mortality was significantly
higher in the control group compared with the IS group (10.7%
and 1.3%, respectively; P = .02 [95% CI, 0.01-0.92]). Specific
cause of death was often unknown, but the primary surgical
team often attributed patient deaths to surgical complica-
tions or the underlying disease process (Table 2). No adverse
events occurred as a result of the intervention.
In our subgroup analysis, we isolated patients with known
or suspected cancer. These patients were more likely to be fe-
male and older than patients without cancer, although the sex
distribution did not reach statistical significance. Patients with
cancer had longer hospital stays, although this factor was pri-
marily due to a long preoperative stay before an elective pro-
cedure. The FVC measurements did not significantly differ be-
tween patients with and without cancer. Mortality for patients
with cancer was 23.1% compared with 4.4% for patients with-
out cancer (Table 3). Incentive spirometry did not appear to
have a statistically significant effect on recovery of pulmo-
nary function between patients with and without cancer. Hos-
pital length of stay and mortality rate tended to be higher in
the control group for patients with cancer, although the sample
size was too small to detect a statistically significant differ-
ence (Table 3).
We also performed subgroup analysis for trauma patients.
Trauma patients were most commonly young men. Neither re-
covery of pulmonary function nor secondary outcomes (hospi-
tal length of stay and mortality) were significantly different be-
tween trauma and nontrauma patients or between intervention
and control groups within the trauma cohort.
Discussion
To our knowledge, this study is the only prospective random-
ized trial in sub-Saharan Africa to investigate the use of IS fol-
Figure 1. Participant Flow
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A CONSORT flow diagram illustrates the design of the randomized controlled
trial comparing control vs intervention (incentive spirometry) groups.
HDU indicates high-dependency unit; ICU, intensive care unit.
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lowing exploratory laparotomy. Our results do not support the
hypothesis that IS improves the recovery of pulmonary func-
tion or reduces hospital length of stay. Although mortality was
significantly higher in the control group, the study was not ad-
equately powered to detect a difference in mortality. In addi-
tion, based on the available medical records, we believe most
of the deaths in this cohort resulted from surgical complica-
tions or the underlying disease process rather than respira-
tory complications.
In our subgroup analysis, we isolated trauma victims and
patients with known or suspected cancer. Trauma patients were
generally young, otherwise healthy men who showed no ben-
efit from the use of IS either in recovery of pulmonary func-
tion or in length of stay. As a result, we would not recom-
mend adding IS to the standard of care for this population.
Patients with cancer, on the other hand, tended to be older and
may have been more deconditioned before surgery. Previous
studies have demonstrated that older patients have a higher





(n = 75) P Value
Age, median (IQR), y 35 (28-53) 33 (23-46) .51
Sex, No. (%)
Male 53 (70.7) 58 (77.3)
.35
Female 22 (29.3) 17 (22.7)
Emergency procedure, No. (%) 59 (78.7) 63 (84.0) .40
Diagnosis, No. (%)
Bowel obstruction 18 (24.0) 15 (20.0)
.11
Peritonitis 10 (13.3) 7 (9.3)
Appendicitis 11 (14.7) 4 (5.3)
Bowel perforation 0 6 (8.0)
Perforated ulcer 1 (1.3) 3 (4.0)
Trauma 7 (9.3) 7 (9.3)
Hernia 6 (8.0) 8 (10.7)
Sigmoid volvulus 11 (14.7) 12 (16.0)
Prior colostomy 1 (1.3) 5 (6.7)
Other 10 (13.3) 8 (10.7)
Operative length, mean (SD), min 71.0 (26.8) 70.8 (27.8) .96
Surgery, No. (%)
.71
Laparotomy 30 (40.0) 29 (38.7)
Abdominal washout 1 (1.3) 2 (2.7)
Appendectomy 10 (13.3) 4 (5.3)
Repair perforation 2 (2.7) 4 (5.3)
Resection
Small intestine 4 (5.3) 5 (6.7)
Large intestine 6 (8.0) 8 (10.7)
Lysis of adhesions 5 (6.7) 7 (9.3)
Mesosigmoidopexy 1 (1.3) 2 (2.7)
Midline hernia repair 6 (8.0) 4 (5.3)
Graham patch 2 (2.7) 1 (1.3)
Colostomy reversal 1 (1.3) 5 (6.7)
Derotation 2 (2.7) 1 (1.3)
Other 5 (6.7) 3 (4.0)
Time from admission to operation, median (IQR), d 0 (0-1) 0 (0-1) .95
Median days to first measurement, median (IQR),d 1 (1-2) 1 (1-2) .86
No. of measurements, mean (SD) 2 (1) 3 (1) .48
Days between first and last measurement, median (IQR) 3 (0-6) 4 (2-6) .74
FVC, mean (SD), L
Initial 0.92 (0.41) 0.90 (0.46) .82
Last 1.21 (0.60) 1.15 (0.55) .55
Difference between first and last measured FVC, mean (SD), L 0.29 (0.64) 0.25 (0.52) .68
Length of stay, median (IQR), d 7 (5-9) 7 (5-12) .67
Death, No. (%) 1 (1.3) 8 (10.7) .02
Abbreviations: FVC, forced vital capacity; IQR, interquartile range.
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risk of PPC,4,30 and these patients may benefit from IS more
than younger patients. However, predicting risk of PPC for tar-
geted intervention can be difficult.4,17,31 Preoperative breath-
ing exercises may be useful in this high-risk population, al-
though prior studies have shown mixed results.6,19,32
Our data are consistent with much of the literature regard-
ing the use of postoperative IS for prevention of PPCs. Low-
risk patients have shown mixed benefit of IS following ab-
dominal or cardiac surgery in terms of recovery of pulmonary
function, prevention of PPC, or reduction in length of hospi-
tal stay.5,21,30,33 Several studies have demonstrated that IS alone
or as part of a combination respiratory program, including IS,
deep breathing, oral care, and early ambulation, is effective at
preventing PPC compared with no intervention.33-36 Al-
though some studies have demonstrated that IS may be more
effective than chest physiotherapy or intermittent positive-
pressure breathing,37-40 many other studies have shown no
benefit of IS compared with alternative therapies in the pre-
vention of PPC.21,30,33,36,37,41-43 Systematic reviews, including
a recent Cochrane analysis, have concluded that IS is not ef-
fective for preventing PPC and that the routine use of IS in low-
risk postoperative patients should be abandoned.5,14,16,21,22,44-49
Despite these recommendations, IS continues to be widely used
in the United States and other developed countries.3,21,44
We made several methodologic decisions in designing this
trialthatmayhavelimitedthegeneralizabilityofourresults.First,
we chose to measure change in FVC over time as an objective
measure of pulmonary recovery. Due to diagnostic limitations,
clinical impressions are not usually confirmed; therefore, esti-
matesoftheincidenceofpulmonarycomplicationswerethought
to be unreliable. Mortality as a secondary outcome was used as
a surrogate marker of pulmonary complications.
Second, we chose to use an intention-to-treat model for this
study. After teaching patients how to use the spirometer, we did
not monitor or quantify IS use in any way to control for patient
compliance with the treatment. In the past, studies have dem-
onstrated that patient compliance with breathing exercises is
similar with or without an IS and that even with improved com-
Table 2. Causes of Death
Sex/Age, y Arm Diagnosis FVC Measurements, No.
FVC, L
Time to
Death, d Cause of DeathInitial Final
M/19 Control Bowel perforation 2 0.74 1.48 16 Septic shock
M/76 Control Cecal volvulus 3 0.95 0.80 10 Wound infection,
intraabdominal abscess,
possible pneumonia
F/70 Control Strangulated incisional
hernia
2 0.43 0.54 9 Respiratory distress,
hypovolemic shock
M/60 Control Obstructive jaundice 2 0.95 1.56 18 Renal failure, liver failure
M/48 Control Gastric outlet
obstruction
2 0.54 0.84 42 Unknown
M/58 IS Pancreatic mass 6 1.03 1.40 22 Readmitted for palliative
care, anemia, respiratory
failure
F/26 Control Sigmoid volvulus 1 0.54 0.54 2 Unknown, watery stools
prior to death
M/29 Control Bowel perforation 1 0.94 0.94 5 Possible septic shock
F/33 Control Peritonitis, pancreatitis 2 0.59 0.50 5 Unknown, possible seizure
on POD 4
Abbreviations: FVC, forced vital capacity; IS, incentive spirometry; POD, postoperative day.














Predicted forced vital capacity (FVC)
values based on line of best fit for
scatterplot of individual patients’
recovery of pulmonary function
postoperatively (P = .68). The shaded
areas indicate the 95% CI for each
group.
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pliance,ISgenerallydoesnotconferasignificantbenefit.14,44 Fur-
thermore,ISisprimarilyapatient-driveninterventionandshould
not require assistance from a nurse or respiratory therapist. Su-
pervising compliance would eliminate this benefit and add sig-
nificantly to the cost of the intervention. In this resource-limited
environment with a dearth of health care professionals, moni-
toring compliance is impractical.
This study has several limitations resulting from the popu-
lation and resource constraints of the study setting. Most pa-
tients underwent emergency exploratory laparotomy, and
hence we could not assess preoperative FVC. Although both
arms were equally affected, this lack of preoperative FVC meant
that we had no reference value with which to determine base-
line pulmonary function. In the elective patient population,
we were unable to predict when the patients would undergo
surgery to obtain a preoperative measurement. A measure-
ment obtained at admission may not have been reflective of
preoperative pulmonary function, as the characteristically long
preoperative hospitalization could have resulted in de-
creased pulmonary reserve.
Although we made every attempt to find and recruit pa-
tients as soon as possible after surgery, in some cases we were
unable to obtain an initial FVC measurement until several days
after surgery. This factor may have resulted in less observ-
able improvement in FVC between the first and last measure-
ment. Previous studies have suggested that IS may be most ben-
eficial when begun immediately after surgery, possibly even
in the post-anesthesia care unit.39,40 To minimize this prob-
lem, we excluded patients who could not be located in the ward
within 3 days of surgery, resulting in a large number of unen-
rolled potential patients.
Finally, our secondary outcome data were limited to mor-
tality and length of hospital stay. We were unable to accurately
record the incidence of pulmonary complications due to the lim-
ited diagnostic capabilities at Kamuzu Central Hospital. In ad-
dition, documentation in this environment is inconsistent and
often incomplete. Specific causes of death are not consistently
documented; however, the primary researcher (A.F.T.) reviewed
the medical records of all patients who died and recorded the
cause of death based on the available documentation. The sur-
gical team documenting complications and cause of death was
blinded to randomization, and documentation was equally poor
in both arms.
Because of firmly held beliefs by many surgeons that IS is ef-
fective, another randomized clinical trial may not be feasible in
the United States. In low- and middle-income countries where
the use of IS is virtually nonexistent, we believe that evidence-
based care should be pursued. Surgical patients in Malawi are dif-
ferent from patients in the United States, and studies from the
United States may not be generalizable to our patient population.
Many surgical procedures are performed urgently in Malawi, and
laparoscopic surgery is unavailable at this institution. Both emer-
gency surgery and open procedures are associated with a higher
risk of PPC. However, this study suggests that IS is not an effec-
tive tool for hastening recovery of pulmonary function and
thereby preventing PPC.
In this resource-poor environment, we must carefully con-
sider the efficacy of any proposed interventions. Although the
devices used in this trial are inexpensive, adopting this inter-
vention would likely draw funds away from other areas. If IS
is no more effective than deep breathing exercises without the
assistance of a device, we would be better served using the
available funds for more efficacious health interventions, such
as preventing surgical site infections or improving timely ac-
cess to surgical care.
Conclusions
The use of IS following laparotomy, as in this study without
measurement of compliance, does not result in a statistically
significant improvement in pulmonary function or reduced
length of hospital stay. With the increasing globalization of sur-
gical care to help attenuate the global burden of diseases treated
surgically, we must continue to emphasize evidence-based
medicine both at home and abroad.
Table 3. Subgroup Analysis by Intervention and Known or Suspected Cancer Diagnosis
Characteristic








(n = 5) P Value
Age, mean (SD), y 38.2 (15.1) 35.9 (15.4) .41 53.4 (16.3) 42.2 (14.2) .23
Sex, No. (%)
Male 50 (74.6) 54 (77.1)
.73
3 (37.5) 4 (80.0)
.11
Female 17 (25.4) 16 (22.9) 5 (62.5) 1 (20.0)
FVC, mean (SD), L
Initial 0.92 (0.39) 0.90 (0.46) .82 0.91 (0.58) 0.95 (0.49) .92
Last 1.22 (0.61) 1.12 (0.54) .13 1.08 (0.48) 1.56 (0.65) .20
Difference between first and
last measured FVC, mean
(SD), L
0.30 (0.65) 0.22 (0.53) .42 0.18 (0.61) 0.61 (0.21) .21
Length of stay, mean (SD), d 9 (8) 9 (8) .81 18 (14) 34 (10) .05
Pulmonary complications,
No. (%)
0 2 (2.9) .21 0 0 >.99
Death, No. (%) 0 6 (8.6) .01 1 (12.5) 2 (40.0) .30
Abbreviation: FVC, forced vital capacity.
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